SRC and neoplasm: Aberrant activation of SRC in cells of the immediate tumor environment can also promote PDAC development and progression via several mechanisms, including inflammation, immune modulation, desmoplasia, angiogenesis, and lymph-angiogenesis (Fig. 3).